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Nedelina Tchangalova, MLS, AHIP4
1National Institutes of Health Clinical Center: Nursing Research and 
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Background: Despite the higher incidence rate of breast cancer among African 
American women compared to their White counterparts, this populations’ 
five-year survival rate has increased in recent years. The growing number of 
African American breast cancer survivors highlights the need for culturally-
appropriate psychosocial interventions to improve survivors’ quality of life and 
psychological wellbeing. 
Objective: This systematic integrative review provides an overview of the current 
research-based psychosocial interventions for African American breast cancer 
survivors supplemented by an overview of the qualitative studies focusing on psy-
chosocial wellbeing. 
Methods: Utilizing the evidence-based PEO framework, a search of five data-
bases was conducted for English-language articles published between 2013–2020: 
Pubmed, Academic Search Ultimate, CINAHL, PsycINFO, and Web of Science. 
Studies were excluded if  there was a lack of primary data collection or if  the 
population in the study was not identified as African American female breast 
cancer survivors. The seven interventions and twenty-one qualitative studies in-
cluded in the final analysis underwent data extraction, critical appraisal using 
SRQR and STROBE checklists, and thematic analysis. 
Results: Twenty-eight studies were identified in the search, including seven 
interventions and twenty-one qualitative studies. Analysis of the interventions 
revealed the importance of alleviating structural barriers and including peer 
support for African American breast cancer survivors. Analysis of the qualita-
tive studies revealed five main themes: 1) spirituality and religion as a protective 
factor, 2) social support as a protective factor, 3) cultural perceptions of breast 
cancer, 4) negative impacts of treatment, and 5) healthcare system experience. 
Conclusion: While study designs differed in the interventions, this review showed 
the critical need for culturally competent psychoeducational interventions for 
African American breast cancer survivors to improve this population’s psycho-
logical wellbeing. The qualitative research highlighted the importance of spiritu-
ality and social support as protective factors for African American breast cancer 
survivors’ psychological wellbeing. Further research using rigorous methodolo-
gies and transparent reporting practices is needed to further evaluate how to most 
effectively alleviate structural barriers that African American breast cancer sur-
vivors face.
CORRESPONDING AUTHOR: Talya Gordon, B.S., National Institutes of 
Health Clinical Center: Nursing Research and Translational Science, Washington, 
DC; talya.gordon@nih.gov
Research Talk 11:00 AM - 12:00 PM
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Introduction: Stigma towards opioid use disorder (OUD) impacts every facet of 
the disorder, from individual health and recovery, to provision of treatment and 
resources, to policymaking. The current opioid epidemic has made some impact 
on public attitudes about those struggling with OUD, but one area that continues 
to lag is support for harm reduction. The current study examines public attitudes 
of OUD stigma related to harm reduction. 
Methods: Data for the study came from a sample (N=1,033) of adults collected 
prior to the launch of a statewide OUD stigma reduction campaign. The survey 
used a quota-based invitation system to produce a representative sample by re-
gion and, separately, by age/sex combined categories. The sample was weighted 
to ensure that it more accurately reflected other demographic characteristics (i.e., 
race, education, location). The survey asked questions regarding attitudes related 
to general views on OUD; positions towards OUD policy; public stigma; and 
self-stigma. 
Results: Nearly 60% of respondents agreed that OUD is an issue in their com-
munity. The majority (78.7%) agreed that there are effective treatments for indi-
viduals with an OUD and 68.5% agreed that long-term recovery from OUD is 
possible. About one-third indicated that they would prefer not to have treatment 
centers near their home. Of all harm reduction policies, respondents were most 
supportive of the availability of naloxone. Over half  (58%) agreed that naloxone 
distribution should be available, half  stated they would be willing to obtain na-
loxone, and two-thirds would be willing to provide naloxone to friends or family 
members of people with an OUD. Only 38.5% supported the availability of 
safe injection facilities. Support varied by location (29.2% of rural respondents 
vs. 41.9% of urban respondents). There was more support for needle exchange 
programs with just under half  (47.8%) agreeing that they should be made avail-
able. Similarly, 47.5% agreed that fentanyl test strips should be available. 
Conclusions: Support for some types of harm reduction has improved, but there 
is still work to be done. Public support for safe injection facilities continues to 
be low, despite consistent findings related to their positive public health impact. 
Results will be discussed within the context of an active statewide stigma reduc-
tion campaign.
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